GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (LTS:0RLB) » Definitions » Cash Payments for Deposits by Banks and Customers

CTI BioPharma (LTS:0RLB) Cash Payments for Deposits by Banks and Customers


View and export this data going back to 2008. Start your Free Trial

What is CTI BioPharma Cash Payments for Deposits by Banks and Customers?

Cash Payments for Deposits by Banks and Customers only applicable to companies reporting Cash Flow from Operations in direct method.


CTI BioPharma (LTS:0RLB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (LTS:0RLB) » Definitions » Cash Payments for Deposits by Banks and Customers
Traded in Other Exchanges
N/A
Address
3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.